INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Expand Bandwidth With A Trusted Regulatory Writing Partner
Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.
-
Switching IRT/RTSM Providers Shouldn't Feel Like Moving Mountains | Korio Makes It Easy
Unveil how structured, repeatable processes can turn RTSM migrations from high‑risk undertakings into predictable transitions.
-
Participant Payments: Navigating Modern Studies
To address the challenges of disbursing clinical trial participant payments globally, sponsors need region-specific payment solutions that navigate local laws and banking systems.
-
Ethical & Regulatory Considerations For Pediatric Gene Therapy
Understanding risk thresholds, consent requirements, and IRB expectations early can prevent redesign, reduce delays, and improve trial feasibility for vulnerable patient populations
-
How A Biotech Startup Transformed Its Clinical Trial Supply Management2/25/2026
Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.
-
Urgent Compliance Recovery Following Vendor Transition5/26/2026
Strong local leadership, clear ownership, and governed oversight drove rapid remediation of legacy safety gaps, restoring regulatory confidence and safeguarding market continuity.
-
Optimizing The Path From First-In-Human To Proof-Of-Concept2/23/2026
By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.
-
Leveraging Functional Service Providers For Drug Development Efficiency8/5/2025
Discover how functional service providers (FSPs) are reshaping clinical research by offering specialized expertise, flexible resources, and cost-effective solutions.
-
Insights From The EACT Clinical Trials Site Personnel Webinar2/7/2025
Collaboration among clinical research stakeholders is breaking financial barriers to support equitable trial access.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Solve the unique challenges of poorly soluble molecules like targeted protein degraders (TPDs), such as PROTACs and molecular glues, seamlessly accelerating your molecule from development to commercialization.
-
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
-
Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.
-
Successfully navigating the complexities of bladder cancer research means mastering specialized delivery methods, managing supply constraints, and leveraging deep site relationships across all phases.
-
Generate accurate study budgets faster with the industry’s most contemporary fair market value (FMV) data for investigator grant costs based on real-world site costs.